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Declaration: This study provides a detailed profile of liver cancer recognition and investigation from 
within primary care. The National Audit of Cancer Diagnosis in Primary Care (NACDPC) enables the 
assessment of  diagnostic time intervals for common cancers. We describe measures and markers of 
diagnostic timelines for patients with liver cancer to raise awareness of the need for further research 
and improvement initiatives in this area. A comparison of these time intervals is made to  diagnostic 
time intervals of other cancers to help better contextualise the size of the challenge.  
 
 
 
 
 
  
 
 
Abstract 
The incidence of liver cancer across Europe is increasing. There is a lack of evidence within the current 
literature regarding the identification and investigation of liver cancer within primary care. We aimed 
to profile liver cancer recognition, assessment and the timeliness of liver cancer diagnosis from within 
the primary care setting in the United Kingdom. Data were obtained and analysed from the National 
Audit of Cancer Diagnosis in Primary Care 2009-10. We calculated the patient interval, primary care 
interval and the number of pre-referral consultations for liver cancer. We then compared these data 
with prior evidence on the respective time variables for other common cancers. The median patient 
interval was 9 days (IQR 0-31 days), and the median primary care interval for liver cancer was 11 days 
(IQR 0-40 days). 21/90 (23.3%) patients had three or more consultations with their general 
practitioner prior to specialist referral. For the three metrics (patient interval, primary care interval, 
and number of pre-referral consultations), liver cancer has average or longer intervals when 
compared with other cancers. The most common symptomatic presentation of liver cancer within 
primary care was with right upper quadrant pain (11%) followed by  decompensated liver failure (9%).  
12% of patients were diagnosed with liver cancer due to an incidental finding of an abnormal liver 
function test. This information provides a detailed and thorough overview of the recognition and 
promptness of liver cancer identification in an English context, and should inform strategies for 
hastening diagnosis pathways.  
 
Key words 
Liver cancer, diagnosis, promptness, primary care interval, patient interval, symptoms, investigations 
 
 
 
 
  
 
 
Introduction 
Primary care plays a crucial role in delivering a high quality health service to the general population. 
In diagnosing cancers, General Practitioners must differentiate between benign and malignant 
conditions. Prompt referral for investigation or specialist opinion is essential to try to achieve early 
diagnosis [1]. Direct comparison with European data regarding 5 year cancer survival rates  has 
revealed that approximately between 6600 to 7500 premature cancer deaths can be avoided annually 
in the United Kingdom, and prompt diagnosis has a role in preventing a proportion of these [2]. The 
English National Awareness and Early Diagnosis Initiative (NAEDI) was set up to facilitate earlier 
diagnosis and improve cancer outcomes [3].  It is well documented that early identification of cancer 
is associated with an improved survival rate [4-7]. In liver cancer, there is evidence that the early 
diagnosis of liver cancer increases the amount of curative treatment strategies available [8-9]. 
Difficulties arise when liver cancer  presents with symptoms of low predictive value, therefore the 
need for further investigations and use of formal diagnostic pathways may not be apparent initially.  
 
The incidence of liver cancer (comprising hepatocellular and intrahepatic cholangiocarcinoma) across 
Europe is increasing [10]. In 2012, nearly 4,000 new cases of liver cancer were diagnosed within the 
United Kingdom [11]. A recent report from the National Office for Statistics highlighted that the 
incidence of liver cancer has increased by 70% for males and 60% for females within the United 
Kingdom between 2003 and 2012 [11]. It is now the 18th most common cancer in England [11]. 
Despite this we are unaware of any previous reports of time intervals in the diagnostic journey for 
liver cancer, apart from one recent paper which reported patients with biliary tract cancer consulting 
their GPs a median of 22 times in the year prior to diagnosis [12]. Hence, we aimed to determine the 
commonest presentation of liver cancer, the patient interval, primary care interval, and the number 
of pre-referral consultations for liver cancer and compare these metrics with existing data for other 
cancers. This is important as it should inform policy for the diagnosis of liver cancer.  
  
 
Methods 
The National Audit of Cancer Diagnosis in Primary Care (NACDPC) 2009–2010 was a collaborative 
effort between about 1170 general practices across England (approximately 14% of all practices) 
[13,14]. GPs were asked to complete a template regarding their patient’s cancer diagnosis. 
Participation was voluntary for GPs. Individual patients who were diagnosed with cancer through 
national screening programmes were not included. Both the patient population and the 
characteristics of participating practices have a high degree of representativeness compared with 
incident cancer cases and non-participating practices. [14,15]For each case, GPs selected the type of 
cancer from a drop-down menu, with both ‘liver cancer’ and ‘gall bladder cancer’ as options. It is 
possible cholangiocarcinomas may have been reported as either liver or gall bladder. The data include 
patient demographics, social-economic status, ethnicity, and various time measures in the diagnostic 
journey. From the dataset, we calculated the patient interval, the primary care interval and the 
number of pre-referral consultations for liver cancer, in the same way as reported for other cancers 
[16,17]. Specific time intervals were calculated, and median intervals were reported in days with 
inter-quartile ranges. Direct comparison with previously published data was made for each of the 
three metrics [16,17]. From the data, we were able to determine the most common presentation of 
liver cancer, in addition to which initial diagnostic investigations were requested from within primary 
care. No ethical approval was required for this study as data were anonymous and non-disclosive.  
 
 
Results 
130 cases of liver cancer were reported. 70 cases of gall bladder cancer were also reported. The data 
for liver cancer, compared with other cancers are presented in Table 1.  
 
 
 Patient interval 
Data were available on the patient interval for 70 (54%) patients with liver cancer. The median patient 
interval was 9 days (IQR 0-31 days). When compared with other cancers for which this interval is 
available [17], liver cancer is eighth equal of the 19 cancers, and similar to other gastro-intestinal 
cancers (stomach, pancreas). 
 
Primary care interval 
Data were available on the patient interval for 85 (66%) patients with liver cancer. The median patient 
interval was 11 days (IQR 0-40 days). When compared with other cancers for which this interval is 
available [16], liver cancer is thirteenth out of the 19 cancers. 
 
Number of pre-referral consultations 
Data were available for the number of pre-referral consultations for 90 (69%) patients with liver 
cancer. The median number was two, with a range from one to ‘in excess of five’ consultations 44 
patients (49%) were referred to a specialist centre following one consultation, and 6 (7%) required in 
excess of five consultations with their GP prior to a specialist referral being made. The proportion of 
patients requiring three or more was 21/90 (23.3%). When compared with other cancers [16], liver 
cancer is twelfth out of 19 cancers, and similar to oesophageal cancer. 
 
 
Liver cancer presentation 
Clinical information regarding the presentation of liver cancer was available for 130 patients. Table 2 
highlights the diversity of the initial presentation of liver cancer within primary care. The most 
common presenting symptom of liver cancer was right upper quadrant pain in 14 patients  (11%), 
decompensated liver failure in 12 patients  (9%) and unintentional weight loss in 12 patients  (9%). 16 
patients (12%) were asymptomatic but were diagnosed incidentally with liver cancer following 
abnormal liver function tests. It was noted that 8 patients (6%) presented with metastatic liver 
disease. The anatomical location of these metastases were bone (4 cases), lung (2 cases), brain (1 
case) and bladder (1 case). 
 
 Liver cancer investigation 
Initial diagnostic tests requested were recorded for each patient. Table 3 presents the diagnostic tests 
requested from within primary care. The most common were blood tests (including liver function) in 
50 cases (38%), followed by abdominal ultrasound in 38 cases (29%). 
 
Discussion 
This study has highlighted key diagnostic time intervals for liver cancer. This information is both useful 
and informative, especially when compared to similar data for a range of other commoner cancers 
within primary care. Prompt diagnosis of liver cancer is crucial – a recent study has reported that 
survival of patients with hepatocellular cancer was adversely effected when treatment was delayed 
[18]. This highlights the importance of identifying liver cancer early, thus allowing prompt referral to 
tertiary care. These findings serve as a benchmark upon which future improvement can be monitored 
by repeat studies. They can also help stimulate comparative studies in other country populations and 
settings. 
 
For all three interval measures, liver cancer was in the middle of the spectrum of diagnostic 
promptness for all three measures examined. Liver cancer does not produce early specific symptoms; 
presentation is usually with large volume tumour disease. Some cancers have been labelled as ‘easier 
to diagnose’ as most patients present with  ‘alarm’ symptoms (such as a lump – breast cancer, or a 
visible skin lesion – melanoma) [19,20]. As the proportion of patients who present with ‘alarm’ 
symptoms varies greatly by cancer, the number of pre-referral consultations also varies greatly 
between cancers. Whilst almost half were referred after just one consultation, just a under a quarter 
had three or more. Overall, the metrics were similar to other gastro-intestinal and solid tumours. Our 
findings highlight that some patients with liver cancer appear to have had fairly typical symptoms 
(with adequate enough specificity / predictive value) and others not , this is very similar to the diverse 
symptom signature of colorectal cancer.  
 Our study highlights the issue that liver cancer can present with a great number of symptoms, none of 
which is dominant among all liver cancer patients. Patients with hepatocellular carcinoma may 
present with jaundice (which will be an ‘alarm’ symptom) but also a variety of much less-specific  
symptoms, ranging from malaise, fatigue, unintentional weight loss to right upper quadrant pain [12, 
21].  This study confirms the great diversity in the presentation of liver cancer. A large case series 
reviewing  hepatocellular cancers presenting symptoms to a tertiary unit, demonstrated that the 
most common symptoms were non-specific abdominal pain and hepatomegaly [22, 23]. Studies have 
highlighted that patients with hepatocellular cancer often present with decompensated liver cirrhosis, 
prior to their formal diagnosis of liver cancer [22]. These patients will present severely 
decompensated, often meeting the criteria of Child’s class B or C cirrhosis [24]. A small proportion 
(9%) may be asymptomatic and be diagnosed incidentally [22]. This finding was consistent with the 
results from this study as 16 patients (12%) were asymptomatic and diagnosed with liver cancer 
following abnormal liver function tests. Therefore general practitioners must have a low threshold for 
requesting relevant investigations when assessing patients with vague and non-specific symptoms. 
This is especially the case when dealing with a cohort of patients who possess risk factors for liver 
cancer, notably individuals with known cirrhosis or hepatitis B or C infection [25] 
 
 
This study has highlighted the difficulty of investigating the potential symptoms of liver cancer within 
primary care. There is no uniformity with regard to the initial investigations requested. They vary 
from cheap, readily available blood tests to advanced imaging of the abdomen. Only 38% of the 
patients within this study had blood tests. This investigation is cheap, minimally invasive and provides 
a wealth of clinical information. This may reflect the fact that general practitioners are unfamiliar with 
the vague , non specific presentation of liver cancer.  The difficulty within clinical practice is that 
general practitioners see many patients with non specific symptoms, where the underlying pathology 
is benign. The diagnostic challenge is identifying individuals with non specific symptoms that are due 
to an underlying malignancy.  One may argue that when dealing with such a clinical scenario that a 
low threshold for investigating cancers that could potentially present insidiously should be adopted. 
This would consist of undertaking screening bloods and basic abdominal imaging such as 
ultrasonography (as this may identify an early mass lesion). Unfortunately this approach would 
accumulate a significant cost to the health service due to the fact of the large number of general 
practitioner consultations that involve vague, non specific symptoms. The percentage of advanced 
imaging tests for the investigation of liver cancer within this study is low, less than 5%. Perhaps a 
possible solution to this would be to train general practitioners and specialist nurses to be able to 
conduct ultrasonographic assessment and interpretation of results from within primary care [26].  
This would allow quick access to a non invasive investigation that would be able to be used as a 
screening tool in patients with non specific, vague abdominal symptoms.  Ultrasound assessment 
could be used to assess for other cancer that present insidiously, such as ovarian and pancreatic 
cancer. However there are financial aspects to consider, mostly the cost of purchase and 
maintenance for an ultrasound machine. In addition one must factor in the cost for formal training of 
conducting the ultrasound assessment and the subsequent interpretation of the images.  Long term 
this may be a cost effective solution as it would decrease the number of referrals to secondary care 
for basic investigations, thus releasing invaluable resources form within the hospital setting. Specialist 
liver units should conduct the definitive diagnostic tests for liver cancer. The role of primary care is to 
identify individuals with underlying malignant disease, instigate initial simple investigative and 
diagnostic tests (such as blood tests, tumour markers and abdominal ultrasound scans) and to refer to 
the specialist units. 
 
This study has produced novel and quantifiable data regarding key diagnostic time intervals for liver 
cancer. The main strength of this work is that it draws on a good quality and established data source 
[16,17]. The main limitations are the relatively small numbers of patients with liver cancer in the 
dataset, and missing data preventing calculations of intervals for some patients. Our study is not able 
to discriminate whether the interval measures that we describe are any different for the two 
dominant liver cancer types (hepatocellular carcinoma and cholangiocarcinoma), and this is a 
limitation to be addressed by future research. There are other issues inherent with the dataset. These 
have previously been reported [16,17], and include: selected self-inclusion of interested, motivated 
practices; potential inaccuracies of the GPs’ recordings or patient intervals; and potential 
inconsistency in the ways GPs interpreted recorded ‘first symptomatic presentation’. A comparison 
between this dataset and the cancer registration statistics suggests that the data is representative of 
the demographics of English cancer patients. 
 
In conclusion, we have reported time intervals in liver cancer diagnosis for the first time and 
compared these with other cancers. Whilst many patients are diagnosed quickly, there remains 
considerable room for improvement in the primary care diagnosis of liver cancer for many patients. 
The initial presentation of liver cancer may by vague and non-specific. Therefore patients presenting 
in such a way must be assessed with a low threshold for further investigations. If there is any clinical 
doubt, these patients should be investigated with baseline blood tests and simple radiological 
investigations prior to specialist referral.   These findings should inform policy and practice to hasten 
the primary care diagnosis of liver cancer.  
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 Tables  
Table 1. Comparison of the diagnostic time intervals of liver cancer with 18 other common cancers 
 
 
Except for liver, other data are reproduced from previous work [11, 14] 
 
 
Cancer type Median Patient 
Interval (IQR) 
Median Primary Care 
Interval (IQR) 
% patients 
 with 3+ consultations prior to 
secondary care referral 
Bladder 2 (0 -16) 4 (0 –18) 14.6 
Brain 7 (1 – 26) 4 (0 –19) 21.4 
Breast 7 (0 – 23) 0 (0 - 1) 2.9 
Colorectal 19 (1 – 60) 7 (0 – 32) 21.3 
Endometrial 14 (1 – 57) 1 (0 – 19) 9.8 
Leukaemia 7 (0 – 30) 6.5 (0 – 23) 17.6 
Liver 9 (0 – 31) 11 (0 – 40) 23.3 
Lung 12 (0 – 33) 14 (3 – 40) 32.8 
Lymphoma 14 (1 – 43) 9 (0 – 32) 25.8 
Melanoma 20 (0 – 69) 0 (0 – 6) 5.4 
Myeloma 14 (0 – 40) 21 (5 – 55) 46.0 
Oesophageal 22 (7 – 46) 7 (0 – 33) 22.6 
Oro-pharyngeal 30 (7 – 62) 6 (0 – 27) 21.9 
Ovarian 14 (2 – 51) 8 (0 – 27) 27.8 
Pancreatic 9.5 (1 – 31) 8 (1 – 35) 31.1 
Prostate 6 (0 – 42) 12 (3 – 28) 15.2 
Renal 3 (0 – 19) 12 (1 – 37) 22.1 
Stomach 9 (0 – 33) 14 (0 – 57) 32.1 
Unknown Primary 7 (0 – 23) 14 (0 – 37.5) 41.2 
Table 2. The presentation of liver cancer within primary care 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presentation of liver cancer Number of patients 
Incidental diagnosis 16 
Right upper quadrant pain 14 
Decompensated liver disease 12 
Weight loss 12 
Jaundice 10 
Epigastric pain 10 
Symptoms from metastatic disease 8 
Abdominal mass 6 
Nausea 5 
Anaemia 4 
Fatigue 4 
Loss of appetite 2 
Pruritus 1 
Rising alpha-feta protein (AFP) level 1 
Found on follow up for a previously 
treated colon cancer 
1 
Not recorded 24 
Table 3. Diagnostic investigations requested within primary care 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic 
investigation 
Percentage of tests requested 
from primary care (n=130) 
Blood tests 50 cases (38%) 
Abdominal Ultrasound 38 cases (29%) 
Chest X-ray 9 cases (7%) 
Abdominal CT scan 7 cases (5%) 
Abdominal MRI 2 cases (2%) 
